Akums’ Haridwar factory receives ANVISA GMP certification for sterile manufacturing plant
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
This approval reflects company’s unwavering commitment that the quality assurance
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Subscribe To Our Newsletter & Stay Updated